Chronicle Journal: Finance

Danaher to buy General Electric's bio pharma business Life Sciences for $21.4 billion

Danaher will buy the bio-pharmaceutical business of General Electric in a $21.4 billion all cash deal, the companies announced on Monday.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.